Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HFM1 is an ATP-dependent DNA helicase that plays a critical role in homologous recombination during meiosis I, particularly facilitating crossover formation, synapsis, and proper spindle assembly/division in germ cells. It is highly expressed in oocytes and spermatocytes, and its activity ensures genome stability and efficient chromosome segregation in gametogenesis. Knockout or genetic mutation of HFM1 leads to misaligned chromosomes, spindle formation defects, loss of ovarian reserve, and infertility. Mutations in HFM1 are associated with primary ovarian insufficiency in women and idiopathic oligo/azoospermia in men; hence, HFM1 is regarded as a significant biomarker and genetic target in reproductive medicine.
Not applicable for drugs, as there are currently no known specific inhibitors or activators.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicase for meiosis 1 (HFM1).